Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
2(22%)
Results Posted
67%(4 trials)

Phase Distribution

Ph not_applicable
5
56%
Ph phase_3
4
44%

Phase Distribution

0

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution9 total trials
Phase 3Large-scale testing
4(44.4%)
N/ANon-phased studies
5(55.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(3)
Completed(6)

Detailed Status

Completed6
Recruiting2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 34 (44.4%)
N/A5 (55.6%)

Trials by Status

not_yet_recruiting111%
completed667%
recruiting222%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DRUG
Total Trials
9